SkinHealth Systems Inc. (SKIN): R&D Expense

Annual figures by period end, from SEC filings.

$5.63M
Year ended 2025-12-31
$5.89M
Trailing 12 months to 2026-06-30
-12.6%
3-year compound annual growth
+10.5%
5-year compound annual growth
$10.10M2019-12-31: $4.61M2020-12-31: $3.41M2021-12-31: $8.20M2022-12-31: $8.44M2023-12-31: $10.10M2024-12-31: $6.30M2025-12-31: $5.63M$5.63M
2019-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$5.63M-10.6%2026-03-12, From 2025-01-01
2024-12-31$6.30M-37.7%2026-03-12, From 2024-01-01
2023-12-31$10.10M+19.6%2026-03-12, From 2023-01-01
2022-12-31$8.44M+3.0%2025-03-12, From 2022-01-01
2021-12-31$8.20M+140.4%2024-03-12, From 2021-01-01
2020-12-31$3.41M-26.1%2023-03-01, From 2020-01-01
2019-12-31$4.61Mn/a2022-03-01, From 2019-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
SkinHealth Systems Inc. (SKIN)2025-12-31$5.63M-10.6%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$71.28M+14.4%
Angiodynamics Inc (ANGO)2026-05-31$29.45M+12.3%
Tactile Systems Technology Inc (TCMD)2025-12-31$8.48M-4.0%
Lemaitre Vascular Inc (LMAT)2025-12-31$14.14M-9.7%
Orthopediatrics Corp (KIDS)2025-12-31$9.10M-17.5%
Cerus Corp (CERS)2025-12-31$67.72M+15.0%
Accuray Inc (ARAY)2026-06-30$37.75M-21.3%
Mimedx Group, Inc. (MDXG)2025-12-31$15.10M+22.3%

Compare SKIN, PRCT, ANGO, TCMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗